Indianapolis, INNCT05108090Now EnrollingIRB Ready

Squamous Cell Carcinoma Clinical Trial in Indianapolis, IN

Access cutting-edge squamous cell carcinoma treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.

Sponsored by Indiana University

Quick Self-Assessment

See if you qualify for this Indianapolis location

Preparing your pre-screening questions…

Expert Care in Indianapolis

Access squamous cell carcinoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related squamous cell carcinoma treatment provided free

Apply for This Indianapolis Location

Check if you qualify for this squamous cell carcinoma clinical trial in Indianapolis, IN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Indianapolis

    Convenient for IN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Indianapolis site if eligible
  4. 4Begin participation

About This Squamous Cell Carcinoma Study in Indianapolis

The purpose of this study is to research if a type of biopsy known as sentinel lymph node biopsy (SLNB) can help in determining the rate of tumor deposits that are hard to detect and identify in node-negative cutaneous squamous cell carcinoma of the head or neck.

Sponsor: Indiana University

Who Can Participate

Inclusion Criteria

Patients ≥ 18 years old at the time of informed consent
Ability to provide written informed consent and HIPAA authorization
Primary or recurrent invasive cutaneous squamous cell carcinoma of the head or neck, clinically staged T2-T4 based on AJCC staging
Clinically and radiographically regional node-negative (no evidence of regional lymph node metastasis or distant metastasis)
Able to undergo general anesthesia for sentinel lymph node biopsy
Able to undergo CT scan with contrast or MRI with contrast
Undergo surgical resection (Moh's or micrographic resection or standard excision with sentinel lymph node biopsy) within 8 weeks of imaging

Exclusion Criteria

Clinical evidence of satellite lesions, in-transit, regional nodal or distant metastases
Known biopsy proven synchronous primary cutaneous squamous cell carcinoma
Pregnant patients
Patients unable to undergo general anesthesia
Patient unable to receive contrasted imaging studies
Patient unable to receive and/or allergic to 99m-Technetium sulfur colloid

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Indianapolis?

Yes, this clinical trial (NCT05108090) has an active research site in Indianapolis, IN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Squamous Cell Carcinoma Treatment Options in Indianapolis, IN

If you're searching for squamous cell carcinoma treatment options in Indianapolis, IN, this clinical trial (NCT05108090) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced squamous cell carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Ready to Join in Indianapolis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Indianapolis, IN